Navigation Links
Alexza Announces Proposed Public Offering of Common Stock and Warrants
Date:2/16/2012

f an offer to buy any securities of Alexza nor shall there be any sale of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

About Alexza Pharmaceuticals, Inc.

Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

ADASUVE™ (Staccato loxapine) is Alexza's lead program, which is being developed for the acute treatment of agitation in adults with schizophrenia or bipolar disorder.  Alexza completed and announced positive results from both of its Phase 3 clinical trials and initially submitted the ADASUVE NDA in December 2009.  In October 2010, the Company received a Complete Response Letter from the FDA regarding the application.  The Company completed an end-of-review meeting with the FDA in December 2010 and a Risk Evaluation and Mitigation Strategy (REMS) guidance meeting with the FDA in April 2011.  The ADASUVE NDA was resubmitted in August 2011, completed an advisory committee meeting in December 2011, received a notice of extension of the Prescription Drug User Fee Act (PDUFA) goal date in January 2012, and has a new PDUFA goal date of May 4, 2012.

In October 2011, the Company
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... A global continuing medical education ... thyroid disorders in Latin America ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/3/2015)... 2015  Obsidian HDS, the developer of PharmaShine ( ... the management of data on pharmaceutical and device industry ... includes the 2014 Open Payments General and Research data ... 30. The data disclosed on Open Payments for 2014 ... providers totaling $6.49 billion and is the largest public ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... Newport Audiology Centers announced that it is relocating ... The new Nashville Operations Center will allow the company ... expand operations across their consumer, business-to-business and workers, compensation ... the opportunities Nashville will bring," said David Gligor, Chief ...
... 25, 2011 The Wound and Hyperbaric ... by the Undersea and Hyperbaric Medical Society (UHMS), the ... that few hospitals and facilities have earned, and identifies ... The super oxygenation offered by hyperbaric treatments can ...
Cached Medicine Technology:Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 2Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 3
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... ... the solar industry’s leading recognition of technical sales expertise from the North American ... Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established national ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... ... rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , has ... from March 4th - 6th, the 2016 (a previous announcement had stated the dates ... take participants from the basic training and fundamentals of nasal surgery through the most ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar Association ... 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law ... of investigating these types of cases. , Each year, New York State residents ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new ... the largest network of independent freestanding emergency rooms in the United States. , “We ... Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... EU legislation has negatively affected the treatment received by children ... February. The meeting was hosted in association with the ... the many hurdles faced by patients and those who care ... Directive (CTD). The Directive (2001/20/EC) has been one of ...
... 14 (HealthDay News) -- Using brain scans, researchers were able ... without dementia and even predict the disorder before it happened, ... day be able to use brain scans to track ... brain-robbing disorder currently has no cure, and its progression cannot ...
... A soldier is struck by an improvised explosive device and ... for osteosarcoma but part of the bone dies as a result. ... heal or lose bone that isn,t successfully grafted. But a ... in San Francisco offers new hope for those who sustain these ...
... TUESDAY, Feb. 14 (HealthDay News) -- Even if kids ... of any physical activity a day will benefit their heart ... and teens who got more moderate to vigorous physical exercise ... and weight, which are important for long-term health. "Parents, ...
... , TUESDAY, Feb. 14 (HealthDay News) -- People who drank ... to 5 pounds over half a year, according to new ... divided into three groups: those who switched to water from ... those who weren,t advised to change beverages but were given ...
... HIV can ramp up production of a type of T ... virus. The discovery, in lymph nodes draining the intestinal tract, ... immune defenses. If the same pattern is found in ... treatment strategy that slows the production of this restraining type ...
Cached Medicine News:Health News:Calls for policy changes as lives put at risk by bureaucracy 2Health News:Calls for policy changes as lives put at risk by bureaucracy 3Health News:Brain Scans May One Day Be Used to Predict Dementia 2Health News:Building bone from cartilage 2Health News:Any Exercise Benefits Kids' Heart Health: Study 2Health News:Any Exercise Benefits Kids' Heart Health: Study 3Health News:Switching to Water, Diet Drinks Linked to Modest Weight Loss 2Health News:SIV infection may lead to increase in immune-suppressive Treg cells 2Health News:SIV infection may lead to increase in immune-suppressive Treg cells 3
Solid 14 mm blades. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: